Cargando…
Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis
Triple-negative breast cancer (TNBC) accounts for ∼20% of all breast cancer (BC) cases. The management of TNBC represents a challenge due to its worse prognosis, heterogeneity and lack of targeted therapy. Moreover, its mechanisms are not fully clear. The aim of the study is to identify crucial gene...
Autores principales: | Lin, Ziyue, Peng, Rui, Sun, Yan, Zhang, Luyu, Zhang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789804/ https://www.ncbi.nlm.nih.gov/pubmed/33305312 http://dx.doi.org/10.1042/BSR20200869 |
Ejemplares similares
-
Identification of key genes in non-small cell lung cancer by bioinformatics analysis
por: Zhang, Li, et al.
Publicado: (2019) -
Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
por: Zhai, Xiuming, et al.
Publicado: (2020) -
ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022) -
Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022) -
Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
por: Song, Xiang, et al.
Publicado: (2019)